Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Incontinence

Inconel alloy 718 Inconel X [11145-80-5] Incontinence devices Indalone [532-34-3]... [Pg.509]

The great quantity of very fine fibers in a meltblown web creates several unique properties such as large surface areas and small (<1 fiva) pore sizes. These have been used in creating new stmctures for hospital gowns, sterile wrap, incontinence devices, oil spill absorbers, battery separators, and special requirement filters. It is expected that much innovation will continue in the design of composite stmctures containing meltblown webs. [Pg.169]

Disposable polypropylene nonwoven fabrics are widely used as the coverstock for disposable baby diapers. The expansion of the disposable diaper market throughout the world has been the primary source of growth in the consumption of polypropylene in the fiber market. In addition, nonwoven polypropylene fabrics are used in a variety of other disposable sanitary products, such as baby wipes, adult incontinence, and feminine hygiene products. Use of polypropylene nonwovens in disposable medical apparel, such as surgical gowns, has increased as a means of reducing the spread of infection. [Pg.421]

Dihydropyridine Z0947 (108) has been identified as a potassium channel opener for use in urinary urge incontinence and an asymmetric synthesis was required for long-... [Pg.318]

TK NK2r antagonists showed interesting activities in preclinical models of depression, anxiety, asthma, gastrointestinal dysmotility and hypersensitivity, and urinary incontinence [1,3]. In clinical, NK2r antagonists antagonize NKA-induced bronchoconstriction and NKA-induced intestinal dysmotility. However, a pilot trial in asthma failed to show any clinical benefit by... [Pg.1190]

OPC-51803 is a highly selective V2R agonist and may prove useful for the treatment of CDI, urinary incontinence, enuresis and pollakiuria. It has a much higher bioavailability after oral application than desmopressin. [Pg.1277]

Mr. Park, a patient in a nursing home, has been receiving clarithromycin (Biaxin) for an upper respiratory infection for 9 days. The nurse assistant reports that he has been incontinent of feces for the past 2 days. Analyze whether this matter should be investigated. [Pg.90]

Transient mild drowsiness, sedation, nausea, depression, lethargy, apathy, confusion, constipation, diarrhea, dry mouth, incontinence, visual disturbances Transient mild drowsiness, sedation, nausea, depression, lethargy, apathy, confusion, constipation, diarrhea, dry mouth, incontinence, visual disturbances... [Pg.275]

Transient mild drowsiness, sedation, nausea, depression, lethargy, apathy, confusion, constipation, diarrhea, dry mouth, incontinence, visual disturbances... [Pg.275]

Nausea, diarrhea, stomatitis, hypotension, anorexia, bone marrow depression, pulmonary congestion, dyspnea, oliguria Dysuria, urinary frequency, cystitis, hematuria, urinary incontinence... [Pg.590]

Clinical signs and symptoms of toxicity are related to the overstimulation of muscarinic, nicotinic, and central nervous system receptors in the nervous system. Muscarinic receptors are those activated by the alkaloid drug muscarine. These receptors are under the control of the parasympathetic nervous system, and their hyperactivity results in respiratory and gastrointestinal dysfunction, incontinence, salivation, bradycardia, miosis, and sweating. Nicotinic receptors are those activated by nicotine. Hyperactivity of these receptors results in muscle fasciculations even greater stimulation results in blockade and muscle paralysis (Lefkowitz et al. 1996 Tafliri and Roberts 1987). Hyperactivity of central nervous system receptors results in the frank neurological signs of confusion, ataxia, dizziness, incoordination, and slurred speech, which are manifestations of acute intoxication. Muscarine and nicotine are not... [Pg.102]

Anaphylactic patients with impending shock, for example, those with incontinence, sudden loss of hearing or vision, dizziness, or collapse, and those with profound or persistent hypotension, require slow intravenous infusion of a dilute epinephrine solution [0.1 mg in 1 ml (1 10,000)]. Continuous hemodynamic monitoring and dose titration by trained and experienced healthcare professionals are essential. Maximum infusion rates of 5-15 ig/min are recommended in adults [2,18,22]. [Pg.215]


See other pages where Incontinence is mentioned: [Pg.683]    [Pg.158]    [Pg.170]    [Pg.171]    [Pg.173]    [Pg.173]    [Pg.405]    [Pg.485]    [Pg.161]    [Pg.798]    [Pg.995]    [Pg.1125]    [Pg.1190]    [Pg.275]    [Pg.276]    [Pg.276]    [Pg.297]    [Pg.306]    [Pg.309]    [Pg.456]    [Pg.458]    [Pg.458]    [Pg.460]    [Pg.460]    [Pg.460]    [Pg.462]    [Pg.626]    [Pg.1353]    [Pg.1732]    [Pg.1995]    [Pg.2077]    [Pg.2078]    [Pg.183]    [Pg.91]    [Pg.375]    [Pg.42]    [Pg.25]   
See also in sourсe #XX -- [ Pg.170 ]

See also in sourсe #XX -- [ Pg.4 ]

See also in sourсe #XX -- [ Pg.189 , Pg.211 ]

See also in sourсe #XX -- [ Pg.255 , Pg.449 , Pg.451 ]

See also in sourсe #XX -- [ Pg.6 ]

See also in sourсe #XX -- [ Pg.432 ]

See also in sourсe #XX -- [ Pg.75 ]

See also in sourсe #XX -- [ Pg.195 ]

See also in sourсe #XX -- [ Pg.279 ]




SEARCH



Adult incontinence

Anticholinergics urinary incontinence with

Benign prostatic hyperplasia urinary incontinence

Bethanechol in urinary incontinence

Bladder incontinence

Bladder, overactive incontinence

Bowel incontinence

Constipation urinary incontinence

Depression urinary incontinence

Desipramine in urinary incontinence

Disposable hygiene products adult incontinence

Drugs and Urinary Incontinence

Duloxetine in urinary incontinence

Fecal incontinence

Giggle incontinence

INCONTINENCE PRODUCT

Imipramine in urinary incontinence

Incontinence appliances

Incontinence daytime

Incontinence detection

Incontinence nighttime

Incontinence of urine

Incontinence pads

Incontinence, urinary

Incontinence, urinary overflow

Incontinence, urinary pathophysiology

Incontinence, urinary pharmacologic treatment

Nortriptyline in urinary incontinence

Oxybutynin in urinary incontinence

Prostate urinary incontinence

Pseudoephedrine in urinary incontinence

Stress urinary incontinence duloxetine

Treatment urinary incontinence

Tricyclic antidepressants incontinence

Urge urinary incontinence

Urinary frequency and incontinence

Urinary incontinence anticholinergics

Urinary incontinence antispasmodics

Urinary incontinence case study

Urinary incontinence catheterization

Urinary incontinence clinical presentation

Urinary incontinence diagnosis

Urinary incontinence donepezil

Urinary incontinence drug-induced

Urinary incontinence duloxetine

Urinary incontinence epidemiology

Urinary incontinence estrogen therapy

Urinary incontinence estrogens

Urinary incontinence evaluation

Urinary incontinence functional

Urinary incontinence imipramine

Urinary incontinence mixed

Urinary incontinence oxybutynin

Urinary incontinence prevention

Urinary incontinence stress

Urinary incontinence surgery

Urinary incontinence surgical

Urinary incontinence tolterodine

Urinary incontinence treating

Urinary incontinence tricyclic antidepressants

Urinary incontinence trospium chloride

Urinary incontinence underactivity)

Urinary incontinence, following

Urinary incontinence, following disease

Urinary tract disorders incontinence

Urine incontinence

© 2024 chempedia.info